Corcept Therapeutics Incorporated (CORT) — Cash Flow-to-Debt Ratio
Corcept Therapeutics Incorporated (CORT) has a Cash Flow-to-Debt Ratio of -0.09x as of March 2026, meaning its operating cash flow of $-16.77 Million could theoretically repay 0% of its total liabilities ($176.89 Million) in one year. Explore Corcept Therapeutics Incorporated (CORT) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Corcept Therapeutics Incorporated Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Corcept Therapeutics Incorporated across 23 annual periods. Also explore Corcept Therapeutics Incorporated assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Corcept Therapeutics Incorporated (2003–2025)
Year-by-year debt coverage analysis for Corcept Therapeutics Incorporated. For market capitalisation and broader financial context, see market cap of Corcept Therapeutics Incorporated.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.75x | $142.00 Million | $188.85 Million | ▼ -38.9% |
| 2024 | 1.23x | $198.07 Million | $160.96 Million | ▲ +11.2% |
| 2023 | 1.11x | $127.04 Million | $114.81 Million | ▼ -25.0% |
| 2022 | 1.47x | $120.32 Million | $81.59 Million | ▼ -57.9% |
| 2021 | 3.50x | $167.89 Million | $47.95 Million | ▲ +11.5% |
| 2020 | 3.14x | $151.97 Million | $48.39 Million | ▼ -5.1% |
| 2019 | 3.31x | $136.12 Million | $41.13 Million | ▲ +2.5% |
| 2018 | 3.23x | $115.67 Million | $35.81 Million | ▲ +56.7% |
| 2017 | 2.06x | $60.94 Million | $29.57 Million | ▲ +206.7% |
| 2016 | 0.67x | $18.39 Million | $27.37 Million | ▲ +617.8% |
| 2015 | 0.09x | $3.13 Million | $33.44 Million | ▲ +113.0% |
| 2014 | -0.72x | $-27.38 Million | $38.02 Million | ▲ +18.3% |
| 2013 | -0.88x | $-37.06 Million | $42.06 Million | ▲ +8.5% |
| 2012 | -0.96x | $-36.02 Million | $37.39 Million | ▲ +82.3% |
| 2011 | -5.45x | $-27.40 Million | $5.03 Million | ▲ +5.6% |
| 2010 | -5.77x | $-22.29 Million | $3.86 Million | ▲ +22.3% |
| 2009 | -7.43x | $-17.97 Million | $2.42 Million | ▼ -16.0% |
| 2008 | -6.40x | $-18.36 Million | $2.87 Million | ▼ -75.8% |
| 2007 | -3.64x | $-10.96 Million | $3.01 Million | ▲ +44.5% |
| 2006 | -6.56x | $-23.24 Million | $3.54 Million | ▼ -35.6% |
| 2005 | -4.84x | $-17.23 Million | $3.56 Million | ▲ +35.7% |
| 2004 | -7.52x | $-13.72 Million | $1.82 Million | ▼ -15.6% |
| 2003 | -6.51x | $-10.00 Million | $1.54 Million | — |